Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 02/23/2015 9:20:24 AM
Post# of 30076
Posted By: Daveludlow
CLIA for LymPro can't be far off! With Lympro's new multivariant data being presented on March 18th -22nd at the Nice, France Conference, I would think CLIA wouldn't be further off than April or May at the latest.

It makes sense that when Gerald makes his play to get AD Doctors around the country to begin recommending Lympro to their AD patients, he will finally do a media blitz to attract more attention. (Interviews on CNN, 60 Minutes, etc, etc)

If Doctors begin using the Lympro test by May or June that will bring in revenue by June or July to add to the revenue trickling in from Clinical Trial users. That is about the same time when the MS diagnostic will start bringing in revenue, as well. By Fall of 2015 the revenue from these 3 sources: Lympro RUO, Lympro CLIA, and MSPrecise, will start becoming significant. It will only get monumentally better from there.

Revenue momentum is starting, and ultimately that is what will make this stock price explode!!!













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site